Limited SARS-CoV-2 spread in childcare centers, finds study
A new study, released as a preprint on the medRxiv* server, adds to the sum of evidence that children do not play a key role […]
In focused attempts to bring an end to the deadly spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the ongoing […] The extent of severity of the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), varies from asymptomatic, mild to severe. Scientists […] Severe coronavirus disease 2019 (COVID-19) is associated with the development of acute respiratory distress syndrome (ARDS), characterized by exacerbated inflammation in the lungs and significantly […] The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread globally, with new variants of concern continuing […] Researchers at the University of Texas, USA, have confirmed the specific mutation in the B.1.1.7 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the […] Researchers based in Belgium have developed a new antibody drug that is highly successful at neutralizing coronavirus disease 2019 (COVID-19) in Syrian hamsters. The new […] The ongoing coronavirus disease 2019 (COVID-19) pandemic has spurred intensive vaccine-related research. As yet, no targeted, safe and effective antivirals have been developed – and […] A team of researchers at Georgetown University Medical Center, USA, investigated how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the immune system’s response during […] With the emergence of new variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic, the […]
COVID-19 vaccination of lactating mothers elicits specific IgA antibodies in breast milk
Is non-severe SARS-CoV-2 infection characterized by early T cell proliferation?
SARS-CoV-2 inhibits the cellular response to interferon
Scientists explore structure of SARS-CoV-2 receptor-binding domain with G485R mutation
N501Y mutation in SARS-CoV-2 responsible for increased viral transmission
Nanobody works against all SARS-CoV-2 variants of concern in animal model
A SARS-CoV-2 spike protein adjuvant vaccine candidate produces durable rapid protection in vivo
Study identifies immune profile of people with severe COVID-19
Llama-derived nanobodies show neutralizing activity against SARS-CoV-2 variants of concern in vitro